LVGI News Alert Limitless Venture Group Inc. (LVGI) 0.0011 09/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Limitless Venture Group Inc. (LVGI) 0.0011 $LVGI

Limitless Venture Group Inc. Announces Its Board of Directors Has Voted and Resolved to Move the Interim CEO Joseph Francella to a Permanent Post as CEO and Chairman of the Board of LVGI
Marketwire - Fri Jun 20, 11:35AM CDT
Limitless Venture Group Inc. (PINKSHEETS: LVGI) (OTC Pink: LVGI) today announced that its board of directors has voted and resolved to move the interim CEO Joseph Francella to a permanent post as CEO and Chairman of the board of LVGI. In a unanimous vote, and citing the strides Joe has made in the past five months with moving products into production and introducing new lines, the board is thrilled to move Joe into a permanent position atop the company and looks forward to entering the revenue generation phase of SLAM Infusination(TM) and HempCore Health(TM) in the coming months.

Limitless Venture Group Inc. Would Like to Inform All Shareholders of Its Former Subsidiary Genetically Enhanced Athletic Research Inc. (G.E.A.R.) That Product to Be Shipped to Vitamin Shoppe on Wednesday April 9, 2014
Marketwire - Wed Apr 02, 10:30AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that its former subsidiary G.E.A.R. to ship large order to Vitamin Shoppe on Wednesday April 9, 2014. G.E.A.R. Shock Series product line to be available at every Vitamin Shoppe across the USA. The G.E.A.R. team also will be in attendance from April 3-7th at the FIBO expo in Cologne, Germany for the launch of G.E.A.R. Europe. Other developments include the finalization of distribution by BodyBuilding.com worlds #1 online retailer of sports nutrition and Nutrition Express another powerhouse online distributor. A lot more to come from G.E.A.R.

Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.

Ku6 Media Co. Controlling Shareholder to Sell 41% Stake to Xu Xudong; Limitless Venture Group Announces The HempCore Health Series
ACCESSWIRE - Tue Apr 01, 11:41PM CDT
McDermott International Inc. (NYSE: MDR) - For an in-depth report on McDermott International Inc. follow: www.BullTrends.com/stockquote/MDR

Limitless Venture Group Inc. Announces Through Its Limitless Health Products Division The HempCore(TM) Health Series
Marketwire - Tue Apr 01, 8:15AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that in response to the ever popular industry trend and overwhelming suggestions from consumers and shareholders alike LVGI through its Limitless Health division has developed and about to enter into production on a line of HEMP based health products called The HempCore(TM) Health Series. This will be a series of four products all based around the health benefits derived from the use of HEMP as the main ingredient. One product will be aimed as heart health and cholesterol reduction, one towards joint pain/arthritis relief, one for brain health/cognitive function and one for anxiety relief.

King Digital Crushed In Its First Day of Trading; Exelixis Shares Fall 40 Percent
ACCESSWIRE - Wed Mar 26, 11:11PM CDT
King Digital Entertainment Plc (NYSE: KING) - For an in-depth report on King Digital Entertainment Plc follow: www.BullTrends.com/stockquote/KING

Limitless Venture Group Inc.'s New CEO Addresses Shareholders
Marketwire - Wed Feb 12, 9:25AM CST
Limitless Venture Group Inc. (OTC Pink: LVGI) new CEO, Joseph Francella, announces the following:

Limitless Venture Group Inc. Announces New CEO Joseph Francella Has Officially Taken His Post
Marketwire - Wed Jan 22, 9:51AM CST
Limitless Venture Group Inc. (OTC Pink: LVGI) - The changing of the guard has officially taken place as of Wednesday, January 15th. Exiting CEO Peter Scalise and myself, CEO Elect Joseph Francella, have collaborated on ways to increase LVGI businesses and solidify the current corporate structure for an exciting new future. Mr. Francella says, "there are many new and exciting products in the pipeline and I can't wait to bring them into fruition. I am also fully aware there are concerns with the share price and I will be studying that situation immediately along with the following areas I have targeted to ensure continued company growth and increased shareholder value and confidence.

Liz Gaspari, The Most Powerful Woman In The Sports Nutrition World, Poised To Take Over The Male Dominated Sports Supplement Industry On December 1, 2013 Named President Of Limitless Venture Group Inc's G.E.A.R. Sports Nutraceutical Subsidiary
ACCESSWIRE - Thu Sep 19, 6:13AM CDT
Holbrook, NY, September 19, 2013 - (Accesswire) - Limitless Venture Group Inc's. (OTCPink: LVGI) G.E.A.R sports Nutraceuticals subsidiary a nutritional supplement company geared toward making everyday people look and feel extra-ordinary, announced today and welcomes industry icon, Liz Gaspari to the company, naming her G.E.A.R.[TM] President.

Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Signs Letter of Intent for Distribution Agreement With Australia's Largest Supplement Retailer/Wholesaler
Marketwire - Wed Sep 18, 8:30AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) G.E.A.R sports Nutraceuticals subsidiary today announced it has signed a Letter of Intent with Australia's Flush Fitness to carry the entire G.E.A.R. line in both Australia and New Zealand.

Limitless Venture Group Inc. Addresses Shareholder Concerns Regarding Recent Common Stock Trading
Marketwire - Mon Sep 16, 9:15AM CDT
Limitless Venture Group Inc's (OTC Pink: LVGI) senior management has released a statement regarding the recent activity in its company stock, while dismayed at the downward pressure in the stock there is no fundamental or corporate event that has taken place to lend credence to the price action and volatility, we have been made aware of certain private transactions with a senior note holder of our company which resulted in the conversion into certain common shares of company stock, we have consulted with our attorney and the note holder and deem the transaction in full compliance with securities rules and regulations. We can only assume these shares were sold into the open market without regard. The current market capitalization of the company is less than a million and a half dollars. The company is reviewing all options to stabilize the market of its company shares and instill confidence in our shareholder base.

Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.) Sports Nutraceuticals Subsidiary Inks Advertising Agreement With Leading Sport and Fitness Magazine
Marketwire - Thu Sep 05, 6:00AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) G.E.A.R sports Nutraceuticals subsidiary today announced it has signed a comprehensive advertising agreement with Muscular Development Magazine. The one-year deal consists of online, print and radio advertisings plus GEAR-TV, which will be on the G.E.A.R. website, as well as a dedicated channel on www.musculardevelopment.com.

Limitless Venture Group Inc. Officially Signs Pete Maletto, World Class Formulator, as Director of Product Development for LVGI's G.E.A.R. Sports Nutraceutical Subsidiary
eTeligis - Wed Sep 04, 10:21AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) today announced that Pete Maletto, President and Sr. Scientist of PTM Food Consulting, would lead the product development team for LVGI's G.E.A.R. Sports Nutraceutical subsidiary.

Former UFC Light Heavyweight Champion Mauricio "SHOGUN" Rua to Wear Limitless Venture Group's Genetically Enhanced Anabolic Research Inc. (G.E.A.R.(TM)) Sports Nutraceuticals Subsidiary Colors in His Nationally Televised Match August 17
Marketwire - Wed Aug 14, 9:24AM CDT
When former UFC Light Heavyweight Champion Mauricio "SHOGUN" Rua steps in the Octagon at Boston's TD Garden, Saturday night, August 17th Limitless Venture Group Inc.'s (OTC Pink: LVGI) G.E.A.R(TM) sports nutraceuticals subsidiary logo will be prominently displayed before the nationally televised event. The Company announced that G.E.A.R.(TM) has signed on to be a Gold Sponsor for SHOGUN as he takes on Chael Sonnen, the self proclaimed "American Gangster."




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading